Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra

J Neurochem. 1989 Mar;52(3):962-70. doi: 10.1111/j.1471-4159.1989.tb02548.x.

Abstract

A superfusion system was used to study the effects of excitatory amino acids (EAA) on release of [3H]dopamine ([3H]DA) previously taken up by rat substantia nigra (SN) slices. The EAA tested (20-250 microM), with the exception of quisqualate and kainate, markedly evoked [3H]DA release from nigral slices when Mg2+ ions were omitted from the superfusion medium. The EAA receptor agonists exhibited the following relative potency in stimulating [3H]DA release: L-glutamate (L-Glu) greater than N-methyl-D-aspartate (NMDA) greater than NM(D,L)A greater than D-Glu much greater than quisqualate = kainate. D-2-Amino-5-phosphonovalerate (100-200 microM), an antagonist for NMDA receptors, substantially reduced [3H]DA release evoked by L-Glu or NMDA. In contrast, L-Glu diethyl ester (100-200 microM) produced a lesser blocking effect on [3H]DA release evoked by the EAA. Further experiments showed that the NMDA-mediated release of [3H]DA was totally suppressed by the omission of Ca2+ or by the addition of tetrodotoxin (0.1 microM) to the superfusion medium. In addition, strychnine, an antagonist for glycine (Gly) receptors, significantly decreased NMDA (100 microM)-evoked as well as glycine (100 microM)-evoked release of [3H]DA from nigral slices. The results shown support the idea that activation of NMDA subtype receptors in SN may trigger a Ca2+-dependent release of DA from dendrites of nigro-striatal DA-containing neurons. Furthermore, a transsynaptic mechanism that may partially involve Gly-containing interneurons is proposed to account for some of the events mediating NMDA receptor activation and DA release in SN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / pharmacology*
  • Animals
  • Aspartic Acid / analogs & derivatives
  • Aspartic Acid / pharmacology
  • Calcium / pharmacology
  • Dendrites / drug effects
  • Dendrites / physiology*
  • Dopamine / metabolism*
  • Glutamates / pharmacology
  • Glutamic Acid
  • Glycine / pharmacology
  • Kainic Acid / pharmacology
  • Kinetics
  • Male
  • N-Methylaspartate
  • Oxadiazoles / pharmacology
  • Quisqualic Acid
  • Rats
  • Rats, Inbred Strains
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter / physiology*
  • Substantia Nigra / metabolism*
  • Substantia Nigra / ultrastructure
  • Tetrodotoxin / pharmacology

Substances

  • Amino Acids
  • Glutamates
  • Oxadiazoles
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neurotransmitter
  • Aspartic Acid
  • Glutamic Acid
  • Tetrodotoxin
  • N-Methylaspartate
  • Quisqualic Acid
  • Kainic Acid
  • Calcium
  • Glycine
  • Dopamine